The molecular biology of galactosemia
β Scribed by Elsas, Louis J; Lai, Kent
- Book ID
- 120736673
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 635 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1098-3600
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Reduced galactose 1-phosphate uridylyltransferase (GALT) activity is associated with the genetic disease type I galactosemia. This results in an increase in the cellular concentration of galactose 1-phosphate. The accumulation of this toxic metabolite, combined with aberrant glycoprotein and glycoli
## Abstract Type I galactosemia results from reduced galactose 1βphosphate uridylyltransferase (GALT) activity. Signs of disease include damage to the eyes, brain, liver, and ovaries. However, the exact nature and severity of the pathology depends on the mutation(s) in the patient's genes and his/h
Galactosemia is a clinically heterogeneous autosomal recessive inborn error of metabolism caused by deficiency of galactose-1-phosphate uridylyltransferase (GALT). Despite the numerous point mutations identified in the GALT gene, the prevalence of these mutations in different ethnic groups has not b
We evaluated 132 galactosemia patients for the Q188R (glutamine-188 to arginine) mutation in the human galactose-1-phosphate uridyltransferase (GALT) gene and for GALT activity in their hemolysates by a sensitive radioisotopic method. In those without any detectable GALT activity (GG), the Q188R mut